Neurocrine Biosciences
NBIX
#1479
Rank
ยฃ9.23 B
Marketcap
ยฃ92.61
Share price
-0.96%
Change (1 day)
-11.95%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of December 2024 : ยฃ2.92 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are ยฃ2.92 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ2.55 B30.35%
2022-12-31ยฃ1.95 B27.52%
2021-12-31ยฃ1.53 B20.64%
2020-12-31ยฃ1.27 B27.78%
2019-12-31ยฃ0.99 B27.29%
2018-12-31ยฃ0.78 B29.33%
2017-12-31ยฃ0.60 B104.46%
2016-12-31ยฃ0.29 B-7.65%
2015-12-31ยฃ0.32 B105.24%
2014-12-31ยฃ0.15 B66.47%
2013-12-31ยฃ93.77 M-22.66%
2012-12-31ยฃ0.12 B36.2%
2011-12-31ยฃ89.02 M-4.85%
2010-12-31ยฃ93.55 M113.78%
2009-12-31ยฃ43.76 M-45.73%
2008-12-31ยฃ80.63 M-42.1%
2007-12-31ยฃ0.13 B-30%
2006-12-31ยฃ0.19 B-28.99%
2005-12-31ยฃ0.28 B3.59%
2004-12-31ยฃ0.27 B-12.82%
2003-12-31ยฃ0.31 B86.63%
2002-12-31ยฃ0.16 B-30.41%
2001-12-31ยฃ0.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ2.22 B-23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.35 B 390.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ3.39 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ61.99 B 2,016.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ106.45 B 3,534.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ172.85 B 5,801.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.01 B-65.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.85 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA